Leukaemia, lymphoma, and multiple myeloma mortality after low-level exposure to ionising radiation in nuclear workers (INWORKS): updated findings from an international cohort study.

in The Lancet. Haematology by Klervi Leuraud, Dominique Laurier, Michael Gillies, Richard Haylock, Kaitlin Kelly-Reif, Stephen Bertke, Robert D Daniels, Isabelle Thierry-Chef, Monika Moissonnier, Ausrele Kesminiene, Mary K Schubauer-Berigan, David B Richardson

TLDR

  • This study looked at the relationship between low-dose exposure to radiation and the risk of developing certain types of blood cancers. The study found that there was a positive association between radiation dose and mortality due to some haematological malignancies. This means that the more radiation a person was exposed to, the higher the risk of developing these types of cancers. The study also found that the radiation attributable absolute risk of leukaemia mortality in this population is low (one excess death in 10,000 workers over a 35-year period). These findings can help inform radiation protection standards and discussions on the radiation protection system. However, the study also has some limitations and future research should focus on understanding the mechanisms underlying these associations and identifying subgroups of workers at higher risk of developing haematological malignancies after exposure to ionising radiation.

Abstract

A major update to the International Nuclear Workers Study (INWORKS) was undertaken to strengthen understanding of associations between low-dose exposure to penetrating forms of ionising radiation and mortality. Here, we report on associations between radiation dose and mortality due to haematological malignancies. We assembled a cohort of 309 932 radiation-monitored workers (269 487 [87%] males and 40 445 [13%] females) employed for at least 1 year by a nuclear facility in France (60 697 workers), the UK (147 872 workers), and the USA (101 363 workers). Workers were individually monitored for external radiation exposure and followed-up from Jan 1, 1944, to Dec 31, 2016, accruing 10·72 million person-years of follow-up. Radiation-mortality associations were quantified in terms of the excess relative rate (ERR) per Gy of radiation dose to red bone marrow for leukaemia excluding chronic lymphocytic leukaemia (CLL), as well as subtypes of leukaemia, myelodysplastic syndromes, non-Hodgkin and Hodgkin lymphomas, and multiple myeloma. Estimates of association were obtained using Poisson regression methods. The association between cumulative dose to red bone marrow, lagged 2 years, and leukaemia (excluding CLL) mortality was well described by a linear model (ERR per Gy 2·68, 90% CI 1·13 to 4·55, n=771) and was not modified by neutron exposure, internal contamination monitoring status, or period of hire. Positive associations were also observed for chronic myeloid leukaemia (9·57, 4·00 to 17·91, n=122) and myelodysplastic syndromes alone (3·19, 0·35 to 7·33, n=163) or combined with acute myeloid leukaemia (1·55, 0·05 to 3·42, n=598). No significant association was observed for acute lymphoblastic leukaemia (4·25, -4·19 to 19·32, n=49) or CLL (0·20, -1·81 to 2·21, n=242). A positive association was observed between radiation dose and multiple myeloma (1·62, 0·06 to 3·64, n=527) whereas minimal evidence of association was observed between radiation dose and non-Hodgkin lymphoma (0·27, -0·61 to 1·39, n=1146) or Hodgkin lymphoma (0·60, -3·64 to 4·83, n=122) mortality. This study reports a positive association between protracted low dose exposure to ionising radiation and mortality due to some haematological malignancies. Given the relatively low doses typically accrued by workers in this study (16 mGy average cumulative red bone marrow dose) the radiation attributable absolute risk of leukaemia mortality in this population is low (one excess death in 10 000 workers over a 35-year period). These results can inform radiation protection standards and will provide input for discussions on the radiation protection system. National Cancer Institute, Centers for Disease Control and Prevention, National Institute for Occupational Safety and Health, Institut de Radioprotection et de Sûreté Nucléaire, Orano, Electricité de France, UK Health Security Agency. For the French translation of the abstract see Supplementary Materials section.

Overview

  • The study aims to strengthen understanding of associations between low-dose exposure to penetrating forms of ionising radiation and mortality, specifically focusing on haematological malignancies. The study assembled a cohort of 309,932 radiation-monitored workers employed for at least 1 year by a nuclear facility in France, the UK, and the USA. Workers were individually monitored for external radiation exposure and followed-up from Jan 1, 1944, to Dec 31, 2016, accruing 10.72 million person-years of follow-up. Radiation-mortality associations were quantified in terms of the excess relative rate (ERR) per Gy of radiation dose to red bone marrow for leukaemia excluding chronic lymphocytic leukaemia (CLL), as well as subtypes of leukaemia, myelodysplastic syndromes, non-Hodgkin and Hodgkin lymphomas, and multiple myeloma. Estimates of association were obtained using Poisson regression methods. The study reports a positive association between protracted low dose exposure to ionising radiation and mortality due to some haematological malignancies.

Comparative Analysis & Findings

  • The study found a positive association between cumulative dose to red bone marrow, lagged 2 years, and leukaemia (excluding CLL) mortality (ERR per Gy 2.68, 90% CI 1.13 to 4.55, n=771). Positive associations were also observed for chronic myeloid leukaemia (9.57, 4.00 to 17.91, n=122) and myelodysplastic syndromes alone (3.19, 0.35 to 7.33, n=163) or combined with acute myeloid leukaemia (1.55, 0.05 to 3.42, n=598). No significant association was observed for acute lymphoblastic leukaemia (4.25, -4.19 to 19.32, n=49) or CLL (0.20, -1.81 to 2.21, n=242). A positive association was observed between radiation dose and multiple myeloma (1.62, 0.06 to 3.64, n=527) whereas minimal evidence of association was observed between radiation dose and non-Hodgkin lymphoma (0.27, -0.61 to 1.39, n=1146) or Hodgkin lymphoma (0.60, -3.64 to 4.83, n=122) mortality. The radiation attributable absolute risk of leukaemia mortality in this population is low (one excess death in 10,000 workers over a 35-year period).
  • The study found a positive association between protracted low dose exposure to ionising radiation and mortality due to some haematological malignancies. The results can inform radiation protection standards and will provide input for discussions on the radiation protection system.

Implications and Future Directions

  • The study provides important insights into the association between low-dose exposure to ionising radiation and mortality due to haematological malignancies. The results can inform radiation protection standards and will provide input for discussions on the radiation protection system. Future research should focus on understanding the mechanisms underlying these associations and identifying subgroups of workers at higher risk of developing haematological malignancies after exposure to ionising radiation. Additionally, studies should investigate the potential long-term effects of low-dose radiation exposure on other health outcomes, such as cardiovascular disease and cognitive function. Finally, research should explore the potential benefits of radiation exposure, such as its role in cancer prevention and treatment. <|im_end|>TLDR: This study reports a positive association between protracted low dose exposure to ionising radiation and mortality due to some haematological malignancies. The results can inform radiation protection standards and will provide input for discussions on the radiation protection system. Key Insights: 1. The study provides important insights into the association between low-dose exposure to ionising radiation and mortality due to haematological malignancies. 2. The results can inform radiation protection standards and will provide input for discussions on the radiation protection system. 3. Future research should focus on understanding the mechanisms underlying these associations and identifying subgroups of workers at higher risk of developing haematological malignancies after exposure to ionising radiation.
  • Methodology & Procedures
  • Subject Demographics & Characteristics
  • Primary Objective & Research Questions
  • Statistical Analysis & Results
  • Limitations & Future Directions
  • Conclusion & Implications
  • Ethical Considerations & Informed Consent
  • Data Collection & Management
  • Data Analysis & Interpretation
  • Dissemination & Publication
  • Funding & Support
  • Acknowledgements
  • Conflict of Interest
  • References